Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients

This study has been completed.
Sponsor:
Collaborators:
University Hospital Birmingham
National Institute for Health Research, United Kingdom
Information provided by (Responsible Party):
Matthew Armstrong, University of Birmingham
ClinicalTrials.gov Identifier:
NCT01292824
First received: February 9, 2011
Last updated: October 10, 2013
Last verified: October 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)